SEC Form EFFECT filed by Aspire Biopharma Holdings Inc.
$ASBP
Biotechnology: Pharmaceutical Preparations
Health Care
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 21, 2025 4:30 P.M. |
| Form: | S-1 | ||||||
| |||||||